Despite enormous progress in the past two decades, the intentional control of bionic prostheses remains a challenge and the ...
A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...
PATHFINDER 2 evaluated the safety and performance of the Galleri ® multi-cancer early detection (MCED) test when used ...
Launch Follows Compelling New Data from Clinical Study that Included Canadian Patients and Researchers TORONTO, Oct. /CNW/ – ...
Former Central Michigan coach Jim McElwain and three of his former staff members face coaching restrictions and potential ...
An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.
Cancer will claim an estimated 618,000 lives in the U.S. in 2025, according to the American Cancer Society. Yet, despite advances in treatment, most ...